Status:
WITHDRAWN
tDCS to Treat Subacute Aphasia
Lead Sponsor:
University of Pennsylvania
Conditions:
Aphasia
Stroke, Acute
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study proposes to use transcranial direct current stimulation (tDCS), a technique by which a very small electrical current (2 mA) is applied to the scalp, along side speech therapy in patients wi...
Detailed Description
Speech therapy is the standard of care nationwide in treating individuals who have had a stroke and are now experiencing aphasia. Speech therapy can help to rehabilitate language skills and supplement...
Eligibility Criteria
Inclusion
- 1\. Presence of aphasia attributable to stroke that occurred between 7 days and 3 months (inclusive) prior to inclusion in the study.
- 2\. Must be able to understand the nature of the study, and give informed consent.
- 3\. English must be their native language where "native" is defined as learning English before the age of 6
Exclusion
- 1\. History of chronic, serious, or unstable neurologic illness(es) other than stroke
- 2\. Current unstable medical illness(es)
- 3\. History of reoccurring seizures or epilepsy
- 4\. Current abuse of alcohol or drugs
- 5\. Active or History of major psychiatric disorder
- 6\. Pregnancy
- 7\. Subjects with metallic objects in the face or head other than dental apparatus such as braces, fillings, and implants.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04048668
Start Date
September 1 2019
End Date
July 1 2024
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Institute for Rehabilitation Medicine
Philadelphia, Pennsylvania, United States, 19146